Reuters logo
BRIEF-Insys Therapeutics reports Q1 loss per share $0.09
May 9, 2017 / 11:08 AM / 7 months ago

BRIEF-Insys Therapeutics reports Q1 loss per share $0.09

May 9 (Reuters) - Insys Therapeutics Inc:

* Insys therapeutics reports first quarter 2017 results

* Q1 adjusted non-GAAP loss per share $0.09

* Q1 loss per share $0.09

* Q1 revenue $36 million versus I/B/E/S view $37.8 million

* Q1 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S

* Q1 earnings per share view $-0.10, revenue view $37.8 million -- Thomson Reuters I/B/E/S

* Insys Therapeutics Inc - cash, cash equivalents and investments were $218.5 million as of March 31, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below